Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Regent Lee at the Nuffield Department of Surgical Sciences (NDS) who has been awarded a grant of £246,226 from Heart Research UK for his research project ‘Using artificial intelligence (AI) for safer CT imaging of blood vessels’.

CT without contrast dye (Figure A) and CT with contrast dye (Figure B)

Computerised tomography (CT or CAT) scans are widely used in all fields of medicine and surgery. Where treatment of a blood vessel is being considered, doctors need a detailed view inside the blood vessel. For example, blood clots are often found inside arteries or veins. The position and shape of the clot, in relation to the blood vessel wall is important for the planning of treatment such as the placement of a stent. 

On routine CT scans, the human eye cannot detect the presence abnormalities inside the blood vessel. An example is the presence of blood clot (Figure A, white arrows point towards the blood vessel). To make it clearer, a special dye, called a contrast agent, is injected into the patient. This makes it easier to visualise the blood flowing through the blood vessel and the blood clot (Figure B). These are called ‘contrast enhanced’ CT scans.

There are several problems with the use of contrast dye. Contrast enhanced CT scans take longer to complete and requires more radiation exposure to the patient. Patients usually get some mild reactions to the contrast dye and may be allergic to it (in which case they cannot have contrast enhance CT scans). Importantly, the use of contrast dye requires the insertion of a needle into the patient’s arm. This is uncomfortable can result in problems such as contrast dye leakage outside the injection site and cause skin problems.  Contrast dye can sometimes damage the kidneys, which is called ‘contrast induced nephropathy’. This can be a particular problem in elderly patients whose kidneys are not working at full capacity. 

Although human eyes cannot tell the difference between blood flow and clot within the blood vessel on a routine CT scan, there are minute details in the scan that can be used to differentiate them. Dr Lee and his team has developed a technology to generate contrast enhanced CT scans without the need to inject contrast dye. HRUK will support Dr Lee’s team to further develop their technology through the Novel and Emerging Technology Award.

If successful, this research will allow diagnosis and treatment of blood vessel conditions with a reduced risk of complications. The reduced scanning time, radiation dose and lower cost would bring important benefits. Furthermore, the method can be extended for diagnosis and treatment planning for other medical conditions where contrast enhanced CT scanning is required. 

'I am grateful for the generous support by Heart Research UK', said Dr Lee. 'Credit goes to our brilliant DPhil student, Anirudh Chandrashekar, for generating the pilot data, and the co-Investigators, Professor Ashok Handa and Professor Vicente Grau Colomer.'

 

 

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Another successful year for SITU NDS

The Surgical Intervention Trials Unit in the Nuffield Department of Surgical Sciences (SITU NDS) has had another successful year, now running ten randomised controlled trials across surgical specialties and securing a total of £32 million in current peer-reviewed grants.

NDS projects awarded CRUK Oxford Cancer Development Fund

Two research projects at the Nuffield Department of Surgical Sciences (NDS) have been awarded pump-prime funding from this year’s CRUK Oxford Centre Development Fund.

Blog posts

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.

Wrap up of 2021

After a brilliant year of hard work and dedication, the SITU team has done some reflection on 2021, focusing on key events, trial progression, and more. Read on to discover how the year 2021 went for the SITU team...